Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmigo Resources Regulatory News (AMGO)

Share Price Information for Amigo Resources (AMGO)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.125 (5.26%)
Bid:
2.25
Ask:
2.75
Spread: 0.50 (22.222%)
Market Cap: £29.75m
AMGO Live PriceLast checked at - London Stock Exchange

Intraday Amigo Resources Share Chart

(Replacement) Clarification on return to lending

18 Jan 2023 10:02

RNS Number : 1241N
Amigo Holdings PLC
18 January 2023
Β 

18 January 2023

Amigo Holdings PLC

Β 

Clarification on return to lending

Amigo Holdings PLC ("Amigo" or "the Company"), a provider of mid-cost credit in the UK, confirms that, as noted in the market update issued on 13 October 2022, the Company's Scheme of Arrangement ("Scheme") condition to return to lending by 26 February 2023 was fulfilled with the initiation of the pilot lending programme in October 2022.

Volume limits during the pilot phase

During the pilot lending period Amigo has agreed with the Financial Conduct Authority ("FCA") certain volume limits. While demand from applicants has been strong, the volume of completed loans has not met the minimum lending volume that is needed to undertake meaningful outcomes testing. This has required the Company to extend the lending pilot period, as described in the market update issued on 16 January 2023.

Volume limits post pilot phase

It is expected that once the FCA is satisfied with the outcomes testing on the pilot lending, the volume limits associated with the pilot will be removed. However, under the terms of the Scheme, Amigo will remain limited to cumulative net originations not exceeding a maximum ofΒ Β£35m,Β until it has completed a further minimumΒ Β£15mΒ Scheme contribution from the proposed capital raise, by no later thanΒ 26 May 2023. The limit of Β£35m is a requirement of the Scheme and is not subject to FCA approval.Β Β 

ENDS

Enquiries

Company

Β 

Amigo Holdings PLC

investors@amigo.me

Kate Patrick

Head of Investor RelationsΒ 

Roger Bennett

Company SecretaryΒ 

Β 

Β 

Media enquiriesΒ 

Β Amigoloans@lansons.com

Tony Langham

07979 692287

Tom BaldockΒ 

Ed Hooper

07860 101715

07783 387713Β 

Peel Hunt LLP

020 7418 8900

James Britton

Oliver Jackson

About Amigo Loans

Amigo is a public limited company registered in England and Wales with registered number 10024479. The Amigo Shares are listed on the Official List of the London Stock Exchange. Since October 2022, Amigo has offered guarantor loans and non-guarantor personal loans under its RewardRate brand. Both products reward customers for on-time payments with an annual, interest-free, payment holiday and the opportunity to reduce the effective APR, encouraging better financial management and facilitating a long-term improvement of customers' credit scores and financial mobility. Amigo has provided guarantor loans in the UK from 2005, offering access to mid‐cost credit to those who are unable to borrow from traditional lenders due to their credit histories. The guarantor loan concept introduces a second individual to the lending relationship, typically a family member or friend with a stronger credit profile than the borrower. This individual acts as guarantor, undertaking to make loan payments if the borrower does not. Amigo's back book of loans issued pre-November 2020 is in the process of being run off with all net proceeds due to creditors under a Court approved Scheme of Arrangement. Amigo Loans Ltd and Amigo Management Services Ltd are authorised and regulated in the UK by the Financial Conduct Authority.

Additional Information

This announcement is not intended to, and does not, constitute or form part of any offer, invitation, or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell, or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise.

This announcement constitutes notice byΒ Amigo Luxembourg S.A.Β (the "Issuer") to the holders of the Issuer's 7.625% Senior Secured Notes due 2024 (for the notes issued pursuant to Rule 144A of the United States Securities Act of 1933, ISIN: XS1533928468 and Common Code: 153392846; for the notes issued pursuant to Regulation S of the United States Securities Act of 1933, ISIN: XS1533928625 and Common Code: 153392862) (the "Notes") issued pursuant to pursuant to Section 4.03(a)(3) of an indenture datedΒ January 20, 2017Β among, inter alia, the Issuer, the guarantors named therein andΒ U.S. Bank Trustees Limited, as trustee and security agent.Β Amigo Holdings PLCΒ is the indirect parent company of the Issuer. This announcement shall constitute a "Report" to holders of the Notes.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCBGGDBBGBDGXI
Date   Source Headline
4th Sep 20233:55 pmRNSNotice of AGM
14th Aug 20235:00 pmRNSAnnual Report and Accounts
27th Jul 20237:00 amRNSFinancial Results for the year ended 31 March 2023
15th Jun 20232:18 pmRNSChange of Registered Office
9th Jun 20237:00 amRNSMarket Update
16th May 20237:00 amRNSBoard change
19th Apr 20237:00 amRNSStatement re. share price movement
3rd Apr 20237:00 amRNSEmployee Share Schemes & Total Voting Rights
3rd Apr 20237:00 amRNSUpdate on Senior Secured Loan Notes
30th Mar 20234:40 pmRNSSecond Price Monitoring Extn
30th Mar 20234:35 pmRNSPrice Monitoring Extension
30th Mar 20233:22 pmRNSUpdate on corporate broker
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20234:40 pmRNSSecond Price Monitoring Extn
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20231:15 pmRNSBoard changes
23rd Mar 20237:01 amRNSScheme of Arrangement Update
13th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20237:36 amRNSUpdate on Capital Raise and Scheme of Arrangement
10th Mar 20237:00 amRNSShare Incentive Plan purchase
9th Mar 20234:40 pmRNSSecond Price Monitoring Extn
9th Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSGeneral Meeting Statement
7th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20234:35 pmRNSPrice Monitoring Extension
27th Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNS3rd Quarter Results
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20237:00 amRNSNotice of General Meeting
14th Feb 20237:14 amRNSStatement re Conclusion of Enforcement Action
10th Feb 202312:00 pmRNSShare Incentive Plan purchase (“SIP”)
6th Feb 20234:40 pmRNSSecond Price Monitoring Extn
6th Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20237:00 amRNSUpdate on Capital Raise and Pilot Lending
18th Jan 202310:02 amRNS(Replacement) Clarification on return to lending
18th Jan 20239:35 amRNSClarification on return to lending
16th Jan 20237:00 amRNSScheme of arrangement update
10th Jan 20234:30 pmRNSShare Incentive Plan purchase
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.